CR UK pairs with Abcam
admin 7th July 2020 Uncategorised 0The partnership will develop and commercialise novel custom antibodies for cancer research More: CR UK pairs with Abcam Source: News
read more
The partnership will develop and commercialise novel custom antibodies for cancer research More: CR UK pairs with Abcam Source: News
read moreA £310 million cut in UK medical research investment is predicted this year More: UK scientists plead with PM for charity partnership fund Source: News
read moreThe product includes the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU More: Novartis banks EC approval for Enerzair Breezhaler Source: News
read moreJ&J sews up 5 years of coronavirus vaccine supply in $480M-plus deal with Emergent kblankenship Mon, 07/06/2020 – 10:12 More: J&J sews up 5 years of coronavirus vaccine supply in 0M-plus deal with Emergent Source: fierce
read moreGSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options aliu Mon, 07/06/2020 – 10:07 More: GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options Source: fierce
read moreSanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients kblankenship Mon, 07/06/2020 – 09:20 More: Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals